Reaction
Metastases To Ovary reporting signals
As of the last recalculation, Metastases To Ovary appears in 313 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is GOSERELIN (PRR 100.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Goserelin | 19 | 100.1 | 100.3 |
| Panitumumab | 16 | 71.5 | 71.6 |
| Ribociclib | 29 | 67.2 | 67.3 |
| Octreotide Acetate | 27 | 64.1 | 64.1 |
| Fulvestrant | 28 | 61.8 | 61.9 |
| Exemestane | 16 | 52.3 | 52.3 |
| Anastrozole Tablets | 15 | 48.8 | 48.8 |
| Irinotecan Hydrochloride | 8 | 42.4 | 42.5 |
| Oxaliplatin | 32 | 31.8 | 31.8 |
| Fluorouracil Cream, 0.5% | 32 | 31.0 | 31.0 |
| Alpelisib | 4 | 30.9 | 30.9 |
| Regorafenib | 5 | 29.1 | 29.1 |